Danaher (DHR) Receives Hold Rating from Royal Bank of Canada

Royal Bank of Canada reiterated their hold rating on shares of Danaher (NYSE:DHR) in a report released on Thursday morning. Royal Bank of Canada currently has a $96.00 target price on the conglomerate’s stock.

Other equities analysts also recently issued reports about the stock. Cowen reiterated a buy rating and set a $90.00 price objective on shares of Danaher in a research note on Wednesday, October 4th. JPMorgan Chase & Co. restated an overweight rating and issued a $95.00 target price on shares of Danaher in a research note on Friday, September 8th. Zacks Investment Research downgraded shares of Danaher from a buy rating to a hold rating in a research note on Tuesday, December 19th. Evercore ISI began coverage on shares of Danaher in a research note on Wednesday, January 3rd. They issued an outperform rating for the company. Finally, Robert W. Baird raised their target price on shares of Danaher from $87.00 to $97.00 and gave the company an outperform rating in a research note on Friday, October 20th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of Buy and a consensus target price of $94.91.

Danaher (NYSE:DHR) traded up $0.59 during midday trading on Thursday, hitting $94.71. 1,880,600 shares of the stock were exchanged, compared to its average volume of 2,526,025. The company has a current ratio of 1.43, a quick ratio of 1.00 and a debt-to-equity ratio of 0.42. Danaher has a 1 year low of $78.97 and a 1 year high of $95.16. The company has a market capitalization of $66,080.00, a P/E ratio of 28.19, a PEG ratio of 2.07 and a beta of 1.03.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.05. Danaher had a net margin of 13.36% and a return on equity of 11.29%. The firm had revenue of $4.53 billion for the quarter, compared to the consensus estimate of $4.47 billion. During the same period last year, the firm earned $0.87 earnings per share. The company’s quarterly revenue was up 9.6% on a year-over-year basis. equities research analysts expect that Danaher will post 3.99 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a $0.14 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $0.56 annualized dividend and a yield of 0.59%. Danaher’s dividend payout ratio (DPR) is 16.67%.

In other news, CAO Robert S. Lutz sold 11,189 shares of Danaher stock in a transaction on Monday, October 23rd. The shares were sold at an average price of $91.66, for a total transaction of $1,025,583.74. Following the completion of the sale, the chief accounting officer now directly owns 18,314 shares in the company, valued at $1,678,661.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Donald J. Ehrlich sold 10,578 shares of Danaher stock in a transaction on Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total transaction of $960,693.96. Following the sale, the director now owns 104,621 shares of the company’s stock, valued at $9,501,679.22. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 273,810 shares of company stock valued at $25,218,813. 12.20% of the stock is owned by insiders.

Several large investors have recently bought and sold shares of DHR. GQG Partners LLC acquired a new stake in shares of Danaher during the second quarter worth $101,000. Zions Bancorporation lifted its stake in shares of Danaher by 118.3% during the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after buying an additional 667 shares during the period. Patten Group Inc. lifted its stake in shares of Danaher by 262.3% during the third quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock worth $114,000 after buying an additional 3,497 shares during the period. Monetary Management Group Inc. lifted its stake in shares of Danaher by 10.7% during the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after buying an additional 150 shares during the period. Finally, Acrospire Investment Management LLC lifted its stake in shares of Danaher by 185.5% during the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after buying an additional 1,100 shares during the period. Institutional investors and hedge funds own 76.05% of the company’s stock.

WARNING: This story was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.com-unik.info/2018/01/08/danaher-dhr-receives-hold-rating-from-royal-bank-of-canada.html.

Danaher Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Analyst Recommendations for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit